Parambir Dulai
@PDulaiMD
Followers
1K
Following
580
Media
5
Statuses
202
IBD Specialist, Director GI Clinical Trials and Precision Medicine @NMGastro, Spatial Biology Lab
Chicago IL
Joined March 2022
@joerogan would love a dialogue on how the NIH funding situation is impacting young Americans. @AmerGastroAssn @CrohnsColitisFn
2
4
10
RT @aruthak: Let's get behind this amazing collaboration between @XboxANZ @Xbox @CureCancerAu to raise vital funds for early career cancer….
0
9
0
RT @IBDimmunology: ASUC trials. interesting. ☑️ @AGA_CGH by experts @ibdseb @ibddoctor @PDulaiMD @PeyrinBiroulet @AmerGastroAssn . ▶️ Tab….
cghjournal.org
Interventional clinical trials in acute severe ulcerative colitis (ASUC) are characterized by substantial heterogeneity due to a lack of consensus in several key areas of trial design—this impedes...
0
5
0
RT @DCharabaty: #AHNIBDSummit24.Positioning Rx in UC @PDulaiMD.✅UC Phenotype & activity.✅Prior TNFi exposure.✅EIM. 📸How he does it👇🏽. ⚡️Exc….
0
14
0
RT @SaadJavedMD: Fantastic turnout and a wonderful morning session headlined by the stellar @DCharabaty, @PDulaiMD and @GIdietitian and Dr….
0
5
0
RT @GKochharMD: Join us for an exciting day of #IBD learning. -> Stellar faculty.-> All pertinent clinical topics.-> Fellowship Grants ava….
0
13
0
RT @BattatMD4IBD: @DCharabaty @Bealoquebea @Dr_ACaballero_ @MondayNightIBD @abbvie @JanssenUS @ign76 @AshkanRA @AngusWorthing @rheumecraig….
pubmed.ncbi.nlm.nih.gov
Two clinical scenarios were identified where FC can be used with confidence for monitoring treatment response to biologics or tofacitinib in patients with UC without the requirement for endoscopy.
0
3
0
Great data for PRO endpoints for ASUC.
Now in @AmJGastro: Achieving resolution of rectal bleeding in acute severe UC in associated with 6 months steroid-free clinical remission and endoscopic improvement. Finally a pragmatic patient-reported treatment target for acute severe UC!
0
1
20
RT @IBDologist: Check out our new thought provoking study🔥🔥.Do 💉have different effect for distal vs extensive UC. TOFA & IFX better for ex….
thelancet.com
These findings underscore the possibility of differential efficacy of medical therapies according to disease distribution. These results warrant further exploration in forthcoming trials to better...
0
5
0
RT @ShermanPrize: The recipients of the Sherman Emerging Leader Prize from 2016 to 2023 showcase the qualities of dedication, innovation, a….
0
4
0
Amazing trip to Korea for @imkasid2024 Thank you for the wonderful hospitality and discussions!.
Day 3 of @imkasid2024 Presidential Plenary session! Breaking the Therapeutic Ceiling in #IBD @BDYE_IBD @PDulaiMD
0
1
24
RT @NarulaNeeraj: Hit the target? Our latest paper in @AGA_CGH finds achieving MM-SES-CD <22.5 and SES-CD <4 in Crohn's disease is associa….
0
19
0
RT @southasianIBD: Team SAIA/@ibdesis would like to wish a Happy Sikh New Year to everyone observing 🙏🏽. @drsumitbhatia @TandonKp @MKaur_MD….
0
4
0
RT @NorthwesternMed: #Colonoscopy has long been the gold standard for #ColonCancer screening, with the added benefit of removing polyps bef….
0
2
0
RT @IJG_Journal: Trends of inflammatory bowel disease from the Global Burden of Disease Study (1990-2019). Out now in IBD issue @IJG_Journa….
0
3
0
RT @ShermanPrize: Calling all healthcare professionals! Nominate a colleague for the prestigious Sherman Prize and advance IBD care. Submit….
0
4
0